Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 14%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Kyowa Kirin Co., Ltd. engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide. The company offers Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; POTELIGEO for the treatment of cutaneous T-cell lymphoma; Nouriast/Nourianz, an adenosine A2A receptor antagonist; G-LASTA, a mobilization of hematopoietic stem cells into peripheral blood for autologous blood stem cell transp...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 81 3 5205 7200
Fax: 81 3 5205 7182
Address:
1-9-2, Otemachi, Chiyoda-ku, Tokyo, Japan
Latest News on KYKOY
No data available.